343 related articles for article (PubMed ID: 16953188)
21. Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
Docena G; Rovedatti L; Kruidenier L; Fanning A; Leakey NA; Knowles CH; Lee K; Shanahan F; Nally K; McLean PG; Di Sabatino A; MacDonald TT
Clin Exp Immunol; 2010 Oct; 162(1):108-15. PubMed ID: 20731675
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 confers antiinflammatory effects in murine macrophages via the MKK3/p38 MAPK pathway.
Wang XM; Kim HP; Song R; Choi AM
Am J Respir Cell Mol Biol; 2006 Apr; 34(4):434-42. PubMed ID: 16357362
[TBL] [Abstract][Full Text] [Related]
23. Increased spontaneous interleukin-10 release from alveolar macrophages in active pulmonary sarcoidosis.
Oltmanns U; Schmidt B; Hoernig S; Witt C; John M
Exp Lung Res; 2003 Jul; 29(5):315-28. PubMed ID: 12746045
[TBL] [Abstract][Full Text] [Related]
24. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.
Berkman N; John M; Roesems G; Jose PJ; Barnes PJ; Chung KF
J Immunol; 1995 Nov; 155(9):4412-8. PubMed ID: 7594602
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and non-smokers by NO2.
Dandrea T; Tu B; Blomberg A; Sandström T; Sköld M; Eklund A; Cotgreave I
Hum Exp Toxicol; 1997 Oct; 16(10):577-88. PubMed ID: 9363475
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
28. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.
McLeish KR; Knall C; Ward RA; Gerwins P; Coxon PY; Klein JB; Johnson GL
J Leukoc Biol; 1998 Oct; 64(4):537-45. PubMed ID: 9766635
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide.
Dinakar C; Malur A; Raychaudhuri B; Buhrow LT; Melton AL; Kavuru MS; Thomassen MJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):217-22. PubMed ID: 10071528
[TBL] [Abstract][Full Text] [Related]
30. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase.
Wang SW; Pawlowski J; Wathen ST; Kinney SD; Lichenstein HS; Manthey CL
Inflamm Res; 1999 Oct; 48(10):533-8. PubMed ID: 10563470
[TBL] [Abstract][Full Text] [Related]
31. The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR; Cunoosamy DM; Fagerås M; Taib Z; Asimus S; Hegelund-Myrbäck T; Lundin S; Pardali K; Kurian N; Ersdal E; Kristensson C; Korsback K; Palmér R; Brown MN; Greenaway S; Siew L; Clarke GW; Rennard SI; Make BJ; Wise RA; Jansson P
Int J Chron Obstruct Pulmon Dis; 2018; 13():1009-1019. PubMed ID: 29628759
[TBL] [Abstract][Full Text] [Related]
32. Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells.
Scicchitano MS; McFarland DC; Tierney LA; Boyce RW; Frazier KS; Schwartz LW; Thomas HC
Blood Cells Mol Dis; 2008; 40(3):370-80. PubMed ID: 18093851
[TBL] [Abstract][Full Text] [Related]
33. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
[TBL] [Abstract][Full Text] [Related]
34. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
[TBL] [Abstract][Full Text] [Related]
35. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
Wadsworth SA; Cavender DE; Beers SA; Lalan P; Schafer PH; Malloy EA; Wu W; Fahmy B; Olini GC; Davis JE; Pellegrino-Gensey JL; Wachter MP; Siekierka JJ
J Pharmacol Exp Ther; 1999 Nov; 291(2):680-7. PubMed ID: 10525088
[TBL] [Abstract][Full Text] [Related]
36. CREB regulates TNF-α-induced GM-CSF secretion via p38 MAPK in human lung fibroblasts.
Koga Y; Hisada T; Ishizuka T; Utsugi M; Ono A; Yatomi M; Kamide Y; Aoki-Saito H; Tsurumaki H; Dobashi K; Yamada M
Allergol Int; 2016 Oct; 65(4):406-413. PubMed ID: 27118435
[TBL] [Abstract][Full Text] [Related]
37. Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis.
Liu HS; Pan CE; Liu QG; Yang W; Liu XM
World J Gastroenterol; 2003 Nov; 9(11):2513-8. PubMed ID: 14606087
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.
Thorley AJ; Ford PA; Giembycz MA; Goldstraw P; Young A; Tetley TD
J Immunol; 2007 Jan; 178(1):463-73. PubMed ID: 17182585
[TBL] [Abstract][Full Text] [Related]
39. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation.
Nick JA; Young SK; Brown KK; Avdi NJ; Arndt PG; Suratt BT; Janes MS; Henson PM; Worthen GS
J Immunol; 2000 Feb; 164(4):2151-9. PubMed ID: 10657669
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo?
Page TH; Brown A; Timms EM; Foxwell BM; Ray KP
Arthritis Rheum; 2010 Nov; 62(11):3221-31. PubMed ID: 20589681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
